Search

Author/Creator Wood, Roxanne

1. Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma: BrUOG329, A Phase I Brown University Oncology Research Group Trial. (February 2021)

Authors:
Elinzano, Heinrich; Toms, Steven; Robison, Jordan; Mohler, Alex; Carcieri, Arieana; Cielo, Deus; Donnelly, Jennifer; Disano, Dylan; Vatketich, John; Baekey, John; Sturtevant, Ashlee; MacKinnon, Kelsey; Wood, Roxanne; Safran, Howard
Journal:
American journal of clinical oncology
Issue:
Volume 44:Number 2(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The Brown University Oncology Group Experience With FOLFOX + Nab-paclitaxel [FOLFOX-A] for Metastatic and Locally Advanced Pancreatic, BrUOG-292 and BrUOG-318. (23rd August 2022)

Authors:
Breakstone, Rimini; Almhanna, Khaldoun; Raufi, Alexander; Beard, Rachel E.; Leonard, Kara-Lynne; Renaud, Jennifer; Kastura, Michaela; Dionson, Sopha; Wood, Roxanne; Sturtevant, Ashlee; Dipetrillo, Thomas; Olszewski, Adam; Safran, Howard
Journal:
American journal of clinical oncology
Issue:
Volume 45:Number 8(2022)
Page Start:
327
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search